The 18-year-old's mom and sister work hard to give her the life she deserves as she battles a rare genetic condition ...

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...

A 30-year-old man was treated for drug-resistant epilepsy through a procedure called temporal labectomy with amygdalo-hippocampectomy by doctors at Meenakshi Super Specialty Hospital.

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.

Atalanta Therapeutics is pioneering RNA interference (RNAi) for the treatment of neurological diseases, having developed a proprietary platform that, for the first time enables RNAi to be deployed ...

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the completion of a $97 million Series B financing to ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

A MARYPORT care home resident died in hospital in Whitehaven four days after choking a piece of meat while eating his lunch, an inquest has heard.

At the bail hearing at Brisbane Magistrates Court on Tuesday, Queensland police prosecutor Jack Scott said the October video ...

This accumulation could elevate their risk of developing late-onset amyloid-related disorders, such as Alzheimer’s disease.

Police officers are attempting to locate a 70-year-old man named Cheyenne Viltz whose family members state they have not ...

A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can ...